Group 1 | Group 1 b | Group 2 | |
---|---|---|---|
N of patients | 32,909 | 7034 | 25,875 |
Follow-up duration (years) mean (±sd) | 2.48 (1.31) | 1.42 (1.34) | 1.78 (1.14) |
Type of index MI | |||
STEMI | 11,270 (34.25%) | 1742 (24.77%) | 9528 (36.82%) |
NSTEMI (or unspecified MI) | 21,639 (65.75%) | 5292 (75.23%) | 16,347 (63.18%) |
Interventions related to index MI | |||
No invasive procedure | 13,793 (41.91%) | 4697 (66.78%) | 9096 (35.15%) |
Coronary angiography only | 4702 (14.29%) | 772 (10.98%) | 3930 (15.19%) |
PCI | 12,203 (37.08%) | 1353 (19.24%) | 10,850 (41.93%) |
CABG | 2211 (6.72%) | 212 (3.01%) | 1999 (7.73%) |
Age (years) | |||
mean (±sd) | 71.98 (12.97) | 78.23 (11.43) | 71.27 (12.84) |
range (min; max) | 18.52; 102.83 | 27.85; 102.83 | 19.50; 103.12 |
Sex | |||
Male | 19,962 (60.66%) | 16,116 (62.28%) | 3846 (54.68%) |
Female | 12,947 (39.34%) | 9759 (37.72%) | 3188 (45.32%) |
Prior cardiovascular comorbidities | |||
Atrial fibrillation | 4758 (14.46%) | 1549 (22.02%) | 3657 (14.13%) |
Major bleedings | 1879 (5.71%) | 635 (9.03%) | 1632 (6.31%) |
Ischemic stroke or TIA | 2679 (8.14%) | 979 (13.92%) | 1575 (6.09%) |
Congestive heart failure | 6413 (19.49%) | 2426 (34.49%) | 4798 (18.54%) |
Hypertension | 29,942 (90.98%) | 6533 (92.88%) | 25,339 (97.93%) |
Hyperlipidemia | 24,104 (73.24%) | 4542 (64.57%) | 22,875 (88.41%) |
Other prior comorbidities | |||
Diabetes mellitus | 8256 (25.09%) | 2304 (32.76%) | 6601 (25.51%) |
Chronic renal failure | 719 (2.18%) | 329 (4.68%) | 500 (1.93%) |
Dementia/Alzheimer’s disease | 1591 (4.83%) | 658 (9.35%) | 1207 (4.66%) |
Severe liver disease | 98 (0.30%) | 37 (0.53%) | 84 (0.32%) |
COPD | 1224 (3.72%) | 415 (5.90%) | 917 (3.54%) |
Malignancy | 2241 (6.81%) | 828 (11.77%) | 1647 (6.37%) |
Index year | |||
2009 | 7885 (23.96%) | 1750 (24.88%) | 6135 (23.71%) |
2010 | 8062 (24.50%) | 1732 (24.62%) | 6330 (24.46%) |
2011 | 8426 (25.60%) | 1760 (25.02%) | 6666 (25.76%) |
2012 | 8536 (25.94%) | 1792 (25.48%) | 6744 (26.06%) |